K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
Jonathan M. L. Ostrem, Ulf Peters, Martin L. Sos et al. · Nature · 2013
Cited by 2,503 works. doi:10.1038/nature12796
Authors
References
- A Cytoplasmic Protein Stimulates Normal N- ras p21 GTPase, But Does Not Affect Oncogenic Mutants
- Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules.
- Inhibition of NIH 3T3 Cell Proliferation by a Mutant ras Protein with Preferential Affinity for GDP
- KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib
- Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation
- KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
- Molecular Switch for Signal Transduction: Structural Differences Between Active and Inactive Forms of Protooncogenic ras Proteins
- The Catalogue of Somatic Mutations in Cancer (COSMIC)
- K-rasOncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung